Role of preliminary registry data in development of a clinical trial for an innovative device: a small but integral piece of a health policy initiative
Autor: | Donald R. Ricci, Joost de Vries, Raphael Blanc |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: | |
Zdroj: | Journal of Market Access & Health Policy, Vol 5, Iss 1 (2017) |
Druh dokumentu: | article |
ISSN: | 2001-6689 20016689 |
DOI: | 10.1080/20016689.2017.1283106 |
Popis: | Establishing a national health policy at a macro level involves the integration of a series of health initiatives across a spectrum of activities, including clinical care. Evaluation of the safety and efficacy of a new medical device ultimately evolves to testing in humans. The pathway to a formal prospective clinical trial includes a stepwise appreciation of pre-clinical data and detailed analysis of data obtained from preliminary registries, where information about appropriate patient selection and use of the device is obtained. Evaluation of procedural and follow-up efficacy and safety data in a preliminary series of cases, chosen to simulate published data, allows the design and conduct of clinical trials that are required to verify preliminary observations, closing the loop on one aspect of modifying health policy decisions. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |